Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-047189
Filing Date
2025-03-05
Accepted
2025-03-05 16:15:11
Documents
14
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d844531d8ka.htm   iXBRL 8-K/A 28417
2 EX-2.1 d844531dex21.htm EX-2.1 474725
  Complete submission text file 0001193125-25-047189.txt   750847

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20250304.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20250304_lab.xml EX-101.LAB 19395
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20250304_pre.xml EX-101.PRE 12125
17 EXTRACTED XBRL INSTANCE DOCUMENT d844531d8ka_htm.xml XML 4641
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33500 | Film No.: 25711196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)